ResMed Inc. (ASX:RMD)

Market Cap	54.55B
Revenue (ttm)	8.05B
Net Income (ttm)	2.11B
Shares Out	n/a
EPS (ttm)	14.29
PE Ratio	25.91
Forward PE	n/a
Dividend	0.47 (1.28%)
Ex-Dividend Date	May 7, 2025

Volume	1,406,828
Average Volume	2,392,116
Open	37.10
Previous Close	36.75
Day's Range	36.60 - 37.17
52-Week Range	27.13 - 40.75
Beta	0.76
RSI	61.37
Earnings Date	Apr 25, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1989
• Employees: 9,980
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: RMD

Financial Performance

In 2024, ResMed's revenue was $4.69 billion, an increase of 10.95% compared to the previous year's $4.22 billion. Earnings were $1.02 billion, an increase of 13.75%.

Financial numbers in USD